Gracey Craig 4/A

4/A · Omada Health, Inc. · Filed Jul 8, 2026

AI-generated summary of this filing

Updated Jul 9, 2026

Omada Health (OMDA) CAO Gracey Craig Exercises Options and Sells Shares

What Happened

Gracey Craig, Chief Accounting Officer of Omada Health (OMDA), executed a same-day exercise-and-sale on June 24, 2026. She exercised 2,083 option shares at $6.57 per share (cost $13,685) and sold 2,083 shares in the open market for a weighted-average price of $19.01 per share (proceeds ~$39,602). The filing shows the related derivative conversion as well (reported at $0 on the Form for the derivative line).
This transaction is effectively a routine option exercise followed by an immediate sale (not a straightforward buy), so it is generally considered a liquidity/compensation action rather than a clear bullish purchase.

Key Details

Transaction date: June 24, 2026.
Exercise: 2,083 shares @ $6.57 = $13,685 (reported as an acquisition).
Sale: 2,083 shares @ weighted avg $19.01 = $39,602 (reported as a disposition). Sale executed in multiple trades at prices from $19.00–$19.03 (footnote F3).
Plan: Sale made pursuant to a 10b5-1 trading plan adopted March 13, 2026 (footnote F2).
Filing status: This is an amended Form 4/A filed July 8, 2026 that restates the original Form 4 (filed 6/26/2026) to include an exercise that was inadvertently omitted (footnote F1).
Vesting note: The options vest 25% after one year from 9/9/2024 and then monthly (1/48th) thereafter (fully vested at four years) (footnote F4).
Shares owned after the transaction: The amended filing adjusted Box 5 to correct beneficial ownership; the specific post-transaction share total is reported in the Form 4/A (not provided here).

Context

Same-day exercise-and-sale is common when insiders exercise vested options for cash proceeds; because this sale was under a prearranged 10b5-1 plan, it was likely scheduled in advance and is typically treated as routine. The amendment corrected an earlier omission and does not necessarily imply new trading intent.

Form 4/AAmended

Period: 2026-06-24

Chief Accounting Officer

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-06-24$6.57/sh+2,083$13,685→ 17,524 total
Sale
Common Stock
[F2][F3][F1]
2026-06-24$19.01/sh−2,083$39,602→ 15,441 total
Exercise/Conversion
Stock Option (Right to Buy)
[F1][F4]
2026-06-24−2,083→ 39,584 total
Exercise: $6.57Exp: 2034-10-23→ Common Stock (2,083 underlying)

Footnotes (4)

[F1]This Form 4/A restates in its entirety the original Form 4 filed on 6/26/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.
[F2]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
[F3]This transaction was executed in multiple trades at prices ranging from $19.00 to $19.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F4]25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Signature

/s/ Nathan Salha, as Attorney-in-Fact for Craig Gracey|2026-07-08

1 file